Share
59 Posts.
lightbulb Created with Sketch. 4
clock Created with Sketch. 18/12/20
18:57
Share
Originally posted by Silverchair:
↑
I'm trying to put some revenue growth estimates together for Clinuvel just on US sales. It looks to be amazing with the speed of the Clinuvel rollout of treatment centres in the US and the fact that patients can be having up to 6 implants as opposed to currently 4 in Europe. So here is a very conservative attempt based on the following assumptions: 34 US EPP treatment centres accredited. Patients will be having 6 implants. $25000 implant price (I think this is conservative). And the final assumption is that each centre will only be treating ONE patient per week - very conservative IMO and meaning every 2 months they start treating the first patient again (This means only 8 Patients per Centre) 272 US EPP patients are treated in total which is a very low market penetration. Maybe they will have more than this but maybe not all will get the full 6 implants so let's see how this works out.EQUALS $40,800,000
Expand
When you look at what's going on with other stocks today (mesoblast etc)it makes you appreciate the stability and steady growth profile of cuv
(20min delay)